» Articles » PMID: 16322420

Patient Satisfaction with Migraine Management by Family Physicians

Overview
Specialty Public Health
Date 2005 Dec 3
PMID 16322420
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Over 70% of the estimated 5 million office visits per year for migraine headache are to family physicians. Both the number of visits and proportion of migraine patients seeking medical care are increasing rapidly. Patient satisfaction with migraine care by primary care physicians is reported to be low but most data are obtained from patients referred to subspecialists or entered in clinical trials. We surveyed patients who consulted family physicians in 10 Kansas practices during 2002 to assess patient satisfaction and investigate any differences between satisfied and unsatisfied migraine patients. Of our 447 respondents, 74% were "satisfied" or "very satisfied" with migraine care by family physicians. Dissatisfied patients were significantly more likely to report moderate or severe migraine-related disability and less likely to use triptans or to have most medications paid by insurance. Dissatisfied patients were twice as likely to have discontinued taking triptans than satisfied patients. Patient satisfaction with migraine treatment in family practice is substantially higher than generally reported. Statistically significant differences exist between satisfied and dissatisfied patients.

Citing Articles

Compliance and patient satisfaction with treatment settings recommended by the medical on-call service 116117 in Germany using computer-assisted structured initial assessment: a cross-sectional observational study accompanying the demand intervention.

Schafer I, Menzel A, Herrmann T, Willms G, Oltrogge J, Luhmann D BMJ Open. 2023; 13(5):e070475.

PMID: 37160385 PMC: 10173980. DOI: 10.1136/bmjopen-2022-070475.


A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases.

Vikelis M, Argyriou A, Antoniou A, Spingos K, Skliros A, Bilias K Medicina (Kaunas). 2023; 59(4).

PMID: 37109692 PMC: 10143091. DOI: 10.3390/medicina59040734.


Patient satisfaction with computer-assisted structured initial assessment facilitating patient streaming to emergency departments and primary care practices: results from a cross-sectional observational study accompanying the DEMAND intervention in....

Schafer I, Menzel A, Herrmann T, Oltrogge J, Luhmann D, Scherer M BMC Prim Care. 2022; 23(1):213.

PMID: 35999511 PMC: 9397153. DOI: 10.1186/s12875-022-01825-5.


DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment.

Lipton R, Munjal S, Brand-Schieber E, Rapoport A CNS Drugs. 2019; 33(4):375-382.

PMID: 30877622 PMC: 6441104. DOI: 10.1007/s40263-019-00614-6.


A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.

Munjal S, Brand-Schieber E, Allenby K, Spierings E, Cady R, Rapoport A J Headache Pain. 2017; 18(1):31.

PMID: 28251391 PMC: 5332324. DOI: 10.1186/s10194-017-0740-3.